Woodline Partners’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
Other funds holding SANA
FP
RCM
MG
Woodline Partners's SANA Position: Q2 2026 in Review
Woodline Partners held its Sana Biotechnology (SANA) position steady in Q2 2026 at 1,317,932 shares worth $4.6M. The position accounts for 0.01% of the portfolio, ranked #712.
Woodline Partners first reported a position in SANA in Q1 2021 and has held it in 22 quarters since. The position peaked at $13.5M in Q1 2021. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.
- Woodline Partners held 1,317,932 shares of Sana Biotechnology worth $4.6M as of Q2 2026.
- Woodline Partners left its Sana Biotechnology share count unchanged in Q2 2026.
- Sana Biotechnology made up 0.01% of Woodline Partners's portfolio in Q2 2026, its #712 holding.
- Woodline Partners first reported a position in Sana Biotechnology in Q1 2021 and has held it in 22 quarters since.
- Woodline Partners's Sana Biotechnology position peaked at $13.5M in Q1 2021.
- 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.
Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.